Primary structure and anticoagulant activity of fucoidan from the sea cucumber Holothuria polii.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 31 07 2018
revised: 18 09 2018
accepted: 15 10 2018
pubmed: 20 10 2018
medline: 18 1 2019
entrez: 20 10 2018
Statut: ppublish

Résumé

Sea cucumber fucoidan is recently endowed with a variety of biological activities. In the present study, we studied the structure and anticoagulant effect of fucoidan from the sea cucumber Holothuria polii (Fuc-Hp). The Fuc-Hp was purified by anion exchange chromatography and its structure was characterized by FT-IR and NMR spectroscopy. Molecular weight measurements were performed by HPSEC-MALLS-dRI. Fuc-Hp anticoagulant activity was measured by activated partial thromboplastin and thrombin times, and by in vitro thrombin inhibition in the presence of antithrombin and heparin cofactor II. The assessment of thrombin generation was investigated using calibrated automated thrombography. Fuc-Hp with a high sulfate content (34.6%) and an average molecular mass of 1376.3 kDa was isolated from H. polii in amount of ~2.7 mg/g dry body wall. Primary structural analysis indicated that Fuc-Hp was mainly composed of a tetrafucose repeating unit branched by glucuronic acid. Fuc-Hp exhibited a high anticoagulant effect mediated essentially by heparin cofactor II and to lesser extent by antithrombin with IC

Identifiants

pubmed: 30340002
pii: S0141-8130(18)32965-9
doi: 10.1016/j.ijbiomac.2018.10.129
pii:
doi:

Substances chimiques

Anticoagulants 0
Polysaccharides 0
fucoidan 9072-19-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1145-1153

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Mohamed Ben Mansour (MB)

Laboratoire de Génétique, Biodiversité et Valorisation des Bioressources (LR11ES41), University of Monastir, Tunisia.

Rafik Balti (R)

Unité de Physiologie Fonctionnelle et Valorisation des Bio-Ressources (UR17ES27), Higher Institute of Biotechnology of Beja, University of Jendouba, PB 382, Habib Bourguiba Avenue, 9000, Beja, Tunisia. Electronic address: rafikbalti1981@gmail.com.

Lamia Yacoubi (L)

Laboratoire de Virologie Clinique, Institut Pasteur de Tunis, Tunisia.

Véronique Ollivier (V)

Université Paris Diderot, INSERM U 1148, Paris, France.

Frédéric Chaubet (F)

INSERM U1148, Laboratory for Vascular Translational Science (LVTS), Institut Galilée, Université Paris 13, Sorbonne Paris Cité, 99 Avenue Jean-Baptiste Clément, Villetaneuse, F-93430, France.

Raoui Mounir Maaroufi (RM)

Laboratoire de Génétique, Biodiversité et Valorisation des Bioressources (LR11ES41), University of Monastir, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH